Cited by 282Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major DepressionPsychological Testing and Assessment

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

Müller, M·2003·Journal of Affective Disorders

DOI 10.1016/s0165-0327(02)00120-9

Open this paper in CoChat — free account

Abstract

Background MADRS cut-off scores for moderate and severe depression were estimated in relation to the Hamilton Depression Rating Scale (HAMD(17)) and the Clinical Global Impressions Scale (CGI).Method HAMD(17), MADRS, and CGI ratings from patients with major depression (DSM-IV) were analyzed (N=85). Receiver operating characteristics (ROC) curves were applied.Results Mean age was 51.4+/-14.5 years, 69% were female. Mean MADRS scores were 23.4+/-13.2, HAMD(17), MADRS, and CGI scores were highly correlated (r>0.85; P<0.0001). Best separation between moderate and severe depression according to CGI criteria was achieved with a MADRS score of 31 (sensitivity 93.5%, specificity 83.3%).Limitations Studies to validate severity gradations including DSM-IV or ICD-10 diagnostic severity categories are recommended.Conclusions Empirically based MADRS cut-off scores to separate moderate from severe depression on the basis of HAMD(17) and CGI severity ratings in patients with major depression were yielded.

Integrity signals

Registry

Crossref · 10.1016/s0165-0327(02)00120-9

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Grade Scores of the Montgomery—Åsberg Depression and the Clinical Anxiety Scales
Snaith, R. P., Harrop, F. M., Newby, D. A., & Teale, C. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.5.599 · Cited by 365
A Comparison of Depression Rating Scales
Kearns, N. P., Cruickshank, C. A., McGuigan, K. J., Riley, S., Shaw, S. P., & Snaith, R. P. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.141.1.45 · Cited by 273
Exactly what does the Hamilton depression rating scale measure?
Gibbons, R. D., Clark, D. C., & Kupfer, D. J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90037-3 · Cited by 223
St John's Wort for depression
Linde, K., & Mulrow, C. D. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448 · Cited by 179
What Do Depression Rating Scales Measure?
Snaith, P. R. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.3.293 · Cited by 166
Efficacy of SSRIs and Newer Antidepressants in Severe Depression
Hirschfeld, R. M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0511 · Cited by 152
Comparative analysis of observer depression scales
Maier, W., & Philipp, M. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02601.x · Cited by 136
Moderate and severe depression
Müller, M. J., Szegedi, A., Wetzel, H., & Benkert, O. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00162-7 · Cited by 116
Self-citation

Show all 22 references

Sorted by citations

Items 101–200 of 281

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
Montgomery, S., Gommoll, C., Chen, C., & Greenberg, W. M. (2014) · CNS Spectrums · doi:10.1017/s1092852914000273 · Cited by 27
A novel joint index based on peripheral blood CD4+/CD8+ T cell ratio, albumin level, and monocyte count to determine the severity of major depressive disorder
Zhou, D., Yu, H., Yao, H., Yuan, S., Xia, Y., Huang, L. F., Shen, Y.-D., Zhang, J., & Chen, W. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03911-5 · Cited by 27
Association of Major Depression With Sexual Dysfunction in Men
Fabre, L. F., Clayton, A. H., Smith, L. C., Goldstein, I., & Derogatis, L. R. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12010004 · Cited by 30
The NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals
Petrovska, J., Coynel, D., Fastenrath, M., Milnik, A., Auschra, B., Egli, T., Gschwind, L., Hartmann, F., Loos, E., Spalek, K., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.007 · Cited by 25
Two-Dimensional Convolutional Neural Network for Depression Episodes Detection in Real Time Using Motor Activity Time Series of Depresjon Dataset
Espino-Salinas, C. H., Galvan-Tejada, C. E., Luna-García, H., Gamboa-Rosales, H., Celaya-Padilla, J. M., Zanella-Calzada, L. A., & Galván-Tejada, J. I. (2022) · Bioengineering · doi:10.3390/bioengineering9090458 · Cited by 27
Major depressive disorder in late life: A multifocus perspective on care needs
Houtjes, W., van Meijel, B., Deeg, D. J. H., & Beekman, A. T. F. (2010) · Aging & Mental Health · doi:10.1080/13607861003801029 · Cited by 25
Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use
Blashill, A. J., Gordon, J. R., & Safren, S. A. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9476-3 · Cited by 25
Predicting and Monitoring Symptoms in Patients Diagnosed With Depression Using Smartphone Data: Observational Study
Ikäheimonen, A., Luong, N., Baryshnikov, I., Darst, R. K., Heikkilä, R., Holmén, J., Martikkala, A., Riihimäki, K., Saleva, O., Isometsä, E. T., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/56874 · Cited by 28
Factors predicting the long-term illness course in a cohort of depressed inpatients
Kuehner, C., & Huffziger, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0379-7 · Cited by 25
Subjective quality of life aspects predict depressive symptoms over time: results from a three‐wave longitudinal study
Kuehner, C., & Huffziger, S. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01436.x · Cited by 23
Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study
Leong, S. L., Glue, P., Manning, P. J., Vanneste, S., Lim, L. J., Mohan, A., & Ridder, D. D. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00851-4 · Cited by 23
Cultural explanatory models of depression i Uganda
Okello, E. S. (2006) · Figshare · Cited by 23
Amygdala and affective responses to infant pictures: Comparing depressed and non‐depressed mothers and non‐mothers
Dudin, A., Wonch, K. E., Davis, A. D., Steiner, M. S., Fleming, A. S., & Hall, G. B. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12790 · Cited by 22
Vortioxetine for Major Depressive Disorder, Vasomotor, and Cognitive Symptoms Associated with the Menopausal Transition
Freeman, M. P., Cheng, L. J., Moustafa, D., Davies, A. C., Sosinsky, A. Z., Wang, B. H., Petrillo, L. F., Hogan, C. S., & Cohen, L. S. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900407 · Cited by 22
Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients
Applebaum, A. J., Otto, M. W., Richardson, M. A., & Safren, S. A. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903313572 · Cited by 22
Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features
Durgam, S., Kozauer, S. G., Earley, W. R., Chen, C., Huo, J., Lakkis, H. D., Stahl, S. M., & McIntyre, R. S. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001964 · Cited by 21
Response styles to depressed mood affect the long-term course of psychosocial functioning in depressed patients
Kuehner, C., & Huffziger, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.019 · Cited by 21
Prevalence of depressive disorders among the very old in the 21st century
Corneliusson, L., Gustafson, Y., & Olofsson, B. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.07.062 · Cited by 24
Relationships between daily mood states and real-time cognitive performance in individuals with bipolar disorder and healthy comparators: A remote ambulatory assessment study
Bomyea, J. A., Parrish, E. M., Paolillo, E. W., Filip, T. F., Eyler, L. T., Depp, C. A., & Moore, R. C. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.1975656 · Cited by 22
Metabolic Status Influences Probiotic Efficacy for Depression—PRO-DEMET Randomized Clinical Trial Results
Gawlik-Kotelnicka, O., Margulska, A., Płeska, K., Skowrońska, A., & Strzelecki, D. (2024) · Nutrients · doi:10.3390/nu16091389 · Cited by 24
Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder
Garcia, F. D., Coquerel, Q., do-Rego, J.-C., Cravezic, A., Bôle‐Feysot, C., Kiive, E., Déchelotte, P., Harro, J., & Fetissov, S. O. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.01.015 · Cited by 20
Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies
Patel, M., Jain, R., Tohen, M. F., Maletic, V., Earley, W. R., & Yatham, L. N. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000344 · Cited by 19
Reduced heart rate variability during mania in a repeated naturalistic observational study
Stautland, A., Jakobsen, P., Fasmer, O. B., Osnes, B., Tørresen, J., Nordgreen, T., & Oedegaard, K. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1250925 · Cited by 18
No Association between Akathisia or Parkinsonism and Suicidality in treatment-Resistant Schizophrenia
Hansen, L., Jones, R. M., & Kingdon, D. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800309 · Cited by 19
How Are Patient Populations Characterized in Studies Investigating Depression in Advanced Cancer? Results From a Systematic Literature Review
Janberidze, E., Hjermstad, M. J., Haugen, D. F., Sigurdardottir, K. R., Løhre, E. T., Lie, H. C., Loge, J. H., Kaasa, S., Knudsen, A. K., Brearley, S. G., et al. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.11.013 · Cited by 20
Changes in attitude towards LAI antipsychotic maintenance treatment: A two-year follow-up study
Pietrini, F., D’Anna, G., Tatini, L., Talamba, G. A., Andrisano, C., Calderani, E., Manetti, M., Prodi, P. R., Ricca, V., & Ballerini, A. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.002 · Cited by 18
Personality Factors Associated With Psychological Distress in Testicular Cancer Survivors
Siafaka, V., Hyphantis, T. N., Alamanos, I., Fountzilas, G., Skarlos, D., Pectasides, D., Mavreas, V. G., & Pavlidis, N. A. (2008) · Journal of Personality Assessment · doi:10.1080/00223890802107958 · Cited by 18
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression
Geoly, A. D., Stimpson, K. H., Espil, F. M., Bentzley, B. S., & Williams, N. (2025) · Brain stimulation · doi:10.1016/j.brs.2025.04.006 · Cited by 18
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis
Stewart, T. D., Hatch, A., Largay, K., Sheehan, J. J., Marler, S. V., Berman, R., & Nelson, J. C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.017 · Cited by 17
Assessing healthy diet affordability in a cohort with major depressive disorders
Rachelle, S. O., Leonie, S., Felice, N. J., Laura, N., Dash, S. R., Josephine, P., & Itsiopoulos, C. (2015) · Journal of Public Health and Epidemiology · doi:10.5897/jphe2014.0668 · Cited by 17
Differentiating the symptoms of posttraumatic stress disorder and bipolar disorders in adults: Utilizing a trauma‐informed assessment approach
Cogan, C. M., Paquet, C. B., Lee, J. Y., Miller, K. E., Crowley, M. D., & Davis, J. L. (2020) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2504 · Cited by 22
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
Rendell, J. M., Shuttleworth, C., Jochim, J., Diamond, P. R., Brett, D., Amit, B. H., Hawton, K. E., McShane, R. H., & Cipriani, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611 · Cited by 17
Is the alliance always a predictor of change in psychotherapy for depression?
Hendriksen, M., Peen, J., Van, R., Barber, J. P., & Dekker, J. (2013) · Psychotherapy Research · doi:10.1080/10503307.2013.847987 · Cited by 16
Potential predictors of depressive relapse following repetitive Transcranial Magnetic Stimulation: A systematic review
Miljevic, A., Bailey, N. W., Herring, S. E., & Fitzgerald, P. B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.006 · Cited by 17
Drunkorexia behaviors and motives, eating attitudes and mental health in Lebanese alcohol drinkers: a path analysis model
Malaeb, D. N., Bianchi, D., Pompili, S., Berro, J., Laghi, F., Azzi, V., Akel, M., Obeïd, S., & Hallit, S. R. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01321-2 · Cited by 15
The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results
Pietrini, F., Spadafora, M., Talamba, G. A., Godini, L., Lelli, L., Arcabasso, S., Manetti, M., & Ballerini, A. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.988268 · Cited by 15
Drug Class Review: Atypical Antipsychotic Drugs
McDonagh, M. S., Peterson, K., Carson, S., Fu, R., & Thakurta, S. (2010) · Cited by 14
The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence
Hobden, B., Schwandt, M. L., Carey, M. L., Lee, M. R., Farokhnia, M., Bouhlal, S., Oldmeadow, C. J., & Leggio, L. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13400 · Cited by 15
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain
Singh, V., Gillespie, T. W., Lane, O. P., Spektor, B., Zarrabi, A. J., Egan, K., Curseen, K. A., Tsvetkova, M., Beumer, J. H., Sniecinski, R. M., et al. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2669 · Cited by 15
Total Sleep Deprivation Followed by Bright Light Therapy as Rapid Relief for Depression: A Pragmatic Randomized Controlled Trial
Ioannou, M., Szabó, Z., Widmark-Jensen, M., Vyrinis, G., Karlsson, C., & Steingrimsson, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.705090 · Cited by 13
Depressive symptoms are specifically related to speech pauses in schizophrenia spectrum disorders
Tan, E. J., Neill, E., Kleiner, J. L., & Rossell, S. L. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115079 · Cited by 11
Psychosocial Features of Clinically Relevant Patient Subgroups With Serious Mental Illness and Comorbid Diabetes
Gunzler, D. D., Sajatovic, M., McCormick, R., Perzynski, A. T., Thomas, C. L., Kanuch, S. W., Cassidy, K. A., Fuentes‐Casiano, E., & Dawson, N. V. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500554 · Cited by 13
Process Evaluation of a Treatment Program for Mood and Anxiety Disorders Among Emerging Adults: Preentry Factors, Engagement, and Outcomes
Osuch, E. A., Vingilis, E. R., Summerhurst, C., Demy, J., Wammes, M., & Arcaro, J. A. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800219 · Cited by 12
Altered functional connectivity in patients with post-stroke fatigue: A resting-state fMRI study
Ren, W., Wang, M., Wang, Q., Huang, Q., Feng, S., Tao, J., Wen, C., Xu, M., He, J., Yang, C., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.129 · Cited by 13
Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction
Smetanka, A., Stara, V., Farský, I., Tonhajzerová, I., & Ondrejka, I. (2019) · Physiology International · doi:10.1556/2060.106.2019.02 · Cited by 13
Is bouldering-psychotherapy a cost-effective way to treat depression when compared to group cognitive behavioral therapy – results from a randomized controlled trial
Schwarzkopf, L., Dorscht, L., Kraus, L., & Luttenberger, K. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-07153-1 · Cited by 12
Prevalence of depression in Parkinson’s disease in a Lebanese tertiary clinic
Ghaddar, A., Fawaz, M. W., Khazen, G., Abdallah, J., & Milane, A. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1087466 · Cited by 12
Predictors of antidepressant response to fluvoxamine obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients
Higuchi, H., Sato, K., Yoshida, K., Takahashi, H., Kamata, M., Otani, K., & Yamaguchi, N. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01797.x · Cited by 12
Azetukalner, a Novel KV7 Potassium Channel Opener, in Adults With Major Depressive Disorder: A Randomized Clinical Trial
Butterfield, N. N., Luzon Rosenblut, C., Fava, M., Correll, C. U., Rothschild, A. J., Murrough, J. W., Mathew, S. J., Beatch, G. N., Grayson, C., Harden, C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.14278 · Cited by 11
Machine learning algorithm‐based estimation model for the severity of depression assessed using Montgomery‐Asberg depression rating scale
Shimamoto, M., Ishizuka, K., Ohtani, K., Inada, T., Yamamoto, M., Tachibana, M., Kimura, H., Sakai, Y., Kobayashi, K., Ozaki, N., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12404 · Cited by 11
Ketamine for major depressive disorder during an inpatient psychiatric admission: Effectiveness, adverse events, and lessons learned
Brody, B. D., Park, N., Christian, A., Shaffer, C. W., Smetana, R. W., Kotbi, N., Russ, M. J., & Kanellopoulos, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.207 · Cited by 11
Augmentation Therapy With Serial Intravenous Ketamine Over 18 Months in a Patient With Treatment Resistant Depression
Hassamal, S., Spivey, M., & Pandurangi, A. K. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000104 · Cited by 12
The effect of second-generation antidepressant treatment on the attention and mental processing speed of patients with major depressive disorder: A meta-analysis study with structural equation models
Gudayol‐Ferré, E., Duarte-Rosas, P., Peró, M., & Guàrdia‐Olmos, J. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114662 · Cited by 10
Discovering the Potential Value of Coenzyme Q10 as an Adjuvant Treatment in Patients With Depression
Majmasanaye, M., Mehrpooya, M., Amırı, H., & Eshraghi, A. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001845 · Cited by 11
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Gajwani, P. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1636 · Cited by 10
Biased attention allocation in major depressive disorder: A replication and exploration of the potential effects of depression history
Lavi, S., Shamai‐Leshem, D., Bar‐Haim, Y., & Lazarov, A. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.058 · Cited by 11
Systematic evaluation of the ‘efficacy‐effectiveness gap’ in the treatment of depression with venlafaxine and duloxetine
Schneider, C., Breilmann, J., Reuter, B., Becker, T. M., & Kösters, M. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13293 · Cited by 12
Validity and Responsiveness of the Work Functioning Impairment Scale in Workers With Depression
Tokutsu, K., Kawazoe, S., Katsuki, A., Muramatsu, K., Makishima, M., Kubo, T., Yoshimura, R., Matsuda, S., & Fujino, Y. (2019) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001753 · Cited by 10
Self- and caregiver-perceived disability, subjective well-being, quality of life and psychopathology improvement in long-acting antipsychotic treatments: a 2-year follow-up study
Pietrini, F., Tatini, L., Santarelli, G., Brugnolo, D., Squillace, M., Bozza, B., Ballerini, A., Ricca, V., & D’Anna, G. (2021) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2021.1912358 · Cited by 10
Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment response
Stolfi, F., Brasso, C., Raineri, D., Landra, V., Mazzucca, C. B., Ghazanfar, A., Scotti, L., Sinella, R., Villari, V., Cappellano, G., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100942 · Cited by 9
Changes in alcohol consumption after treatment for depression: a secondary analysis of the Swedish randomised controlled study REGASSA
Strid, C., Hallgren, M. Å., Forsell, Y., Kraepelien, M., & Öjehagen, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028236 · Cited by 9
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10
Tatini, L., D’Anna, G., Pietrini, F., Calligaris, E., Ballerini, A., & Ricca, V. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000359 · Cited by 9
Cognitive-affective processes and suicidality in response to repetitive transcranial magnetic stimulation for treatment resistant depression
Terpstra, A. R., Vila‐Rodriguez, F., LeMoult, J., Chakrabarty, T., Nair, M. A., Humaira, A., Gregory, E., & Todd, R. M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.10.041 · Cited by 9
Chronic pain trials often exclude people with comorbid depressive symptoms: A secondary analysis of 346 randomized controlled trials
Cheng, D. K.-Y., Ullah, M., Gage, H., Moineddin, R., & Sud, A. (2023) · Clinical Trials · doi:10.1177/17407745231182010 · Cited by 9
Validación en Colombia del instrumento para evaluación de la depresión Montgomery-Åsberg Depression Rating Scale (MADRS)
Cano, J. F., Gómez–Restrepo, C., & Rondón, M. (2015) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2015.08.006 · Cited by 9
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers
Daniels, S., Horman, T., Lapointe, T., Melanson, B. A., Storace, A., Kennedy, S. H., Frey, B. N., Rizvi, S. J., Hassel, S., Müller, D. J., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.108 · Cited by 11
A Comprehensive Review on Major Depressive Disorder: Exploring Etiology, Pathogenesis and Clinical Approaches
Mehra, A., Khanna, J., Singh, G., Sachdeva, V., & Bedi, N. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00308-y · Cited by 8
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial
Durgam, S., Earley, W. R., Kozauer, S. G., Mo, Y., Lakkis, H. D., Edwards, J. B., Kornstein, S. G., & D, M. F. M. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250292 · Cited by 9
Transcutaneous electrical cranial-auricular acupoint stimulation versus escitalopram for modulating the brain activity in mild to moderate major depressive disorder: An fMRI study
Ma, Y., He, J., Lu, X., Sun, J., Guo, C., Luo, Y., Gao, S., Liu, Y., Zhang, Z., Rong, P., et al. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137414 · Cited by 8
New ways to cope with depression—study protocol for a randomized controlled mixed methods trial of bouldering psychotherapy (BPT) and mental model therapy (MMT)
Kind, L., Luttenberger, K., Leßmann, V., Dorscht, L., Mühle, C., Müller, C., Siegmann, E., Schneider, S., & Kornhuber, J. (2023) · Trials · doi:10.1186/s13063-023-07629-x · Cited by 7
Randomised Controlled Trial of Interpersonal Psychotherapy and Cognitive-behavioural Therapy for Depression
Luty, S. E., Carter, J. D., McKenzie, J. M., Rae, A. M., FRAMPTON, C. M. A., Mulder, R., & Joyce, P. R. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.1.foc110 · Cited by 8
An Automated Mobile Mood Tracking Technology (Mood 24/7): Validation Study
Kumar, A., Wang, M., Riehm, A., Yu, E., Smith, T., & Kaplin, A. I. (2020) · JMIR Mental Health · doi:10.2196/16237 · Cited by 8
Inter-rater reliability among psychiatrists when assessing depression according to the Montgomery–Åsberg Depression Rating Scale
Geijer, J., Baigi, A., & Aiff, H. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2021.1918240 · Cited by 8
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotics as a Predictor of Relapse in Schizophrenia Spectrum Disorders: A 1-Year Pilot Study
D’Anna, G., Rotella, F., Santarelli, G., Scannerini, S., Fanelli, A., Ricca, V., & Ballerini, A. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000990 · Cited by 9
No predictors of antidepressant patient response to milnacipran were obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale in Japanese patients with major depressive disorders
Higuchi, H., Sato, K., Yoshida, K., Takahashi, H., Kamata, M., Otani, K., & Yamaguchi, N. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01755.x · Cited by 8
Do Negative Cognitive Style and Personality Predict Depression Symptoms and Functional Outcomes in Severe Bipolar and Unipolar Disorders?
Jones, S. H., Twiss, J., & Anderson, I. M. (2009) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2009.2.4.343 · Cited by 8
The prevalence of depression in women with pregnancy‐related pelvic girdle pain: A systematic review and meta‐analysis
Halliday, B., Chatfield, S., Hosking, J., & Freeman, J. A. (2024) · Health Science Reports · doi:10.1002/hsr2.2308 · Cited by 12
Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data
Vieta, E., McIntyre, R. S., Yu, J., Aronin, L. C., Kramer, K., & Nguyen, H. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.119 · Cited by 7
Lifestyle in bipolar disorder: A cross-sectional study
Simjanoski, M., Cardoso, T. D. A., Frey, B. N., Minuzzi, L., Boni, R. B. D., Balanzá‐Martínez, V., & Kapczinski, F. P. (2023) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2023.04.001 · Cited by 7
Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients
Stamouli, S. S., Yfantis, A., Lambousis, E., Liakouras, A., Lagari, V., Tzanakaki, M., Giailoglou, D., Legault, M., & Parashos, I. A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902810375 · Cited by 7
Symptoms of epilepsy and organic brain dysfunctions in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department
Vaaler, A. E., Morken, G., Linaker, O. M., Sand, T., Kvistad, K. A., & Bråthen, G. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-63 · Cited by 7
Response Rate Obtained Using Milnacipran Depending on the Severity of Depression in the Treatment of Major Depressive Patients
Sugawara, Y., Higuchi, H., Yoshida, K., Takahashi, H., Kamata, M., Naito, S., Sato, K., & Shimizu, T. (2006) · Clinical Neuropharmacology · doi:10.1097/00002826-200601000-00003 · Cited by 7
Depression in Older Adults in Nursing Homes: A Review of the Literature
McCarthy-Zelaya, I. (2016) · doi:10.15760/honors.259 · Cited by 7
OBF-Psychiatric, a motor activity dataset of patients diagnosed with major depression, schizophrenia, and ADHD
Garcia-Ceja, E., Stautland, A., Riegler, M. A., Halvorsen, P., Hinojosa, S., Ochoa‐Ruiz, G., Berle, J. Ø., Førland, W., Mjeldheim, K., Oedegaard, K. J., et al. (2025) · Scientific Data · doi:10.1038/s41597-025-04384-3 · Cited by 10
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis
Nishi, A., Sawada, K., Uchida, H., Mimura, M., & Takeuchi, H. (2022) · Pharmacopsychiatry · doi:10.1055/a-1934-9856 · Cited by 6
Treating depression in an outpatient setting: Predictors of patient response to bouldering psychotherapy, cognitive behavioural therapy or exercise alone
Luttenberger, K., Donath, C., Graessel, E., Kornhuber, J., Schlüter, A., Dorscht, L., & Kind, L. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2898 · Cited by 6
Results of a Transpersonal, Narrative, and Phenomenological Psychotherapy for Psychosis
Mehl‐Madrona, L., Jul, E., & Mainguy, B. (2014) · CIIS Digital Commons (California Institute of Integral Studies) · doi:10.24972/ijts.2014.33.1.57 · Cited by 6
Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation vs. Escitalopram for Patients With Mild-to-Moderate Depression (TECAS): Study Design for a Randomized Controlled, Non-inferiority Trial
Yang, S.-C., Qin, Z., Yang, X., Chan, M. Y., Zhang, S., Rong, P., Hou, X., Jin, G., Xu, F., Liu, Y. U., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.829932 · Cited by 6
Guía de atención integral para la detección temprana y diagnóstico del episodio depresivo y trastorno depresivo recurrente en adultos. Atención integral de los adultos con diagnóstico de episodio depresivo o trastorno depresivo recurrente
Peñaranda, A. P. B., Valencia, J. G., Guarín, M. R., Borrero, Á. E. A., Castro, S., Bradford, A. M. D. L. H., Riveros, P. M., Jaramillo, L. E., Brito, E., Acosta, C. A. P., et al. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60045-7 · Cited by 7
Pharmacopsychiatry
Gründer, G. (2026) · Pharmacopsychiatry · doi:10.1055/s-00000054 · Cited by 6
Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial
Maji, S., Mishra, A., Mohapatra, D., Mishra, B. R., Jena, M., Srinivasan, A., & Maiti, R. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116257 · Cited by 5
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study
Salles, J., Stéphan, F., Molière, F., Bennabi, D., Haffen, É., Bouvard, A., Walter, M., Allauze, E., Llorca, P., Genty, J. B., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.11.063 · Cited by 7
Validation of the Montgomery-Åsberg depression rating scale in depressed patients in Serbia
Mihajlović, G., Vojvodić, P., Vojvodic, J., Andonov, A., & Hinić, D. (2021) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh200401004m · Cited by 5
Ketamine Treatment in Depression: A Systematic Review of Clinical Characteristics Predicting Symptom Improvement
Lowe, D. J. E., Müller, D. J., & George, T. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200423094423 · Cited by 5
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
Wang, X., Fan, Y., Li, G., & Li, H. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000350 · Cited by 4
The role of the communicated treatment rationale on treatment outcome: study protocol for a randomized controlled trial
Henrich, L., Wilhelm, M., Lange, P., & Rief, W. (2023) · Trials · doi:10.1186/s13063-023-07557-w · Cited by 4
Vortioxetine in the Treatment of Major Depressive Disorder Among Working Patients in Routine Clinical Practice: An Analysis of a Post-Marketing Surveillance Study in South Korea
Moon, S. W., Kim, J. W., Kim, D. H., Adair, M., Åström, D. O., Reines, E. H., Lee, M., & Kim, G. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s478804 · Cited by 4
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression
Conway, C. R., Rush, A. J., Gordon, C., Preskorn, S., Sackeïm, H. A., Aaronson, S. T., McIntyre, R. S., Lee, Y.-C. (., Shy, O., Tran, Q., et al. (2025) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2025.100121 · Cited by 4
Memory complaints moderate the concordance between self-report and electronically monitored adherence in adults with type 2 diabetes
Shapira, A., Kane, N. S., Tanenbaum, M. L., Hoogendoorn, C. J., & Gonzalez, J. S. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108205 · Cited by 5
Assessment of Anxiety and Depressive Symptoms in the Early Post-stroke Period
Todorov, V., Dimitrova, M., Todorova, V., & Mihaylova, E. (2020) · Folia Medica · doi:10.3897/folmed.62.e49453 · Cited by 4

Authors: Müller, M.
Affiliations: Johannes Gutenberg University Mainz (DE)
Corresponding author: Müller, M
ORCID: Müller, M
Venue: Journal of Affective Disorders
Publisher: Elsevier BV
Published: 2003-12
Volume: 77
Issue: 3
Pages: 255-260
ISSN: 0165-0327 (ISSN-L)
DOI: 10.1016/s0165-0327(02)00120-9
OpenAlex: W1979534890
Cited by: 282
References: 22
Citations by year: 2026: 18 · 2025: 26 · 2024: 30 · 2023: 23 · 2022: 15 · 2021: 20 · 2020: 11 · 2019: 12 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 16
FWCI: 3.36
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Affective Disorders (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: Montgomery-Asberg Depression Rating Scale, depression severity, moderate depression, severe depression, cut-off values, Hamilton Depression Rating Scale, Clinical Global Impression Scale, major depressive disorder, sensitivity and specificity
MeSH terms: Adult, Aged, Depressive Disorder, Diagnosis, Differential, Female, Humans, Male, Mental Status Schedule, Middle Aged, Reference Values, Severity of Illness Index, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks